ArticleGastroenterology research and practice2012

Irinotecan plus mitomycin C as second-line chemotherapy for advanced gastric cancer resistant to fluoropyrimidine and Cisplatin: a retrospective study.

Kohei Ogawa et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.